Sudeep Pharma
NSE: SUDEEPPHRM · Pharmaceuticals
Snapshot
Unlock Sudeep Pharma's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sudeep Pharma Limited is a manufacturer and supplier of excipients, mineral salts, and specialty ingredients for the pharmaceutical, food, and nutrition sectors. The company provides a diverse range of mineral-based solutions, including calcium, zinc, and iron, alongside micronutrient premixes and encapsulated ingredients.
Business Model
The company generates revenue through the manufacturing, processing, and global distribution of pharmaceutical excipients, nutraceutical ingredients, and food additives. It operates across the entire value chain, including the import, export, marketing, and testing of chemical and healthcare products.
- Incorporation Year:1989
Growth Outlook
Growth is driven by the increasing demand for functional foods, dietary supplements, and infant nutrition products globally. The company continues to expand its portfolio of specialized formats, such as liposomal and spray-dried ingredients, to cater to evolving healthcare and consumer goods requirements.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory oversight in international markets, requiring continuous adherence to global pharmaceutical and food safety standards.
- Supply Chain Volatility. Fluctuations in the cost and availability of raw materials, such as mineral salts and chemical precursors, may impact profit margins.
- Currency Risk. As an exporter to the United States, Europe, and the United Kingdom, the company is exposed to foreign exchange rate volatility.
- Competitive Pressure. The specialty ingredients market is highly competitive, necessitating constant innovation and investment in manufacturing capabilities to maintain market share.
Start your research today
Unlock AI insights, financials, peers and live data on Sudeep Pharma and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Sudeep PharmaSUDEEPPHRM | ₹15,014 Cr | 80.76 | 57.82 | — | 38.7% | 20.8% | 25.3% | — |
Alembic Pharmaceuticals Ltd.APLLTD | ₹15,886 Cr | 22.91 | 13.84 | 14.1% | 15.8% | 12.7% | 14.3% | -15.8% |
NATCO Pharma Ltd.NATCOPHARM | ₹14,842 Cr | 12.97 | 11.39 | -20.7% | 38.7% | 13.6% | 13.5% | -3.1% |
Concord Biotech Ltd.CONCORDBIO | ₹14,825 Cr | 54.32 | 33.68 | -6.7% | 39.7% | 14.2% | 18.5% | -15.1% |
Marksans Pharma LimitedMARKSANS | ₹14,811 Cr | 28.64 | 17.41 | 57.4% | 25.7% | 31.9% | 39.6% | +90.4% |
Jubilant Pharmova Ltd.JUBLPHARMA | ₹14,726 Cr | 41.59 | 12.91 | 16.3% | 15.0% | 5.3% | 6.5% | -13.2% |
As of Q1 FY27
Financials
Sudeep Pharma
NSE: SUDEEPPHRM · Pharmaceuticals
Snapshot
Unlock Sudeep Pharma's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Sudeep Pharma Limited is a manufacturer and supplier of excipients, mineral salts, and specialty ingredients for the pharmaceutical, food, and nutrition sectors. The company provides a diverse range of mineral-based solutions, including calcium, zinc, and iron, alongside micronutrient premixes and encapsulated ingredients.
Business Model
The company generates revenue through the manufacturing, processing, and global distribution of pharmaceutical excipients, nutraceutical ingredients, and food additives. It operates across the entire value chain, including the import, export, marketing, and testing of chemical and healthcare products.
- Incorporation Year:1989
Growth Outlook
Growth is driven by the increasing demand for functional foods, dietary supplements, and infant nutrition products globally. The company continues to expand its portfolio of specialized formats, such as liposomal and spray-dried ingredients, to cater to evolving healthcare and consumer goods requirements.
Key Risks
- Regulatory Compliance. The company faces stringent regulatory oversight in international markets, requiring continuous adherence to global pharmaceutical and food safety standards.
- Supply Chain Volatility. Fluctuations in the cost and availability of raw materials, such as mineral salts and chemical precursors, may impact profit margins.
- Currency Risk. As an exporter to the United States, Europe, and the United Kingdom, the company is exposed to foreign exchange rate volatility.
- Competitive Pressure. The specialty ingredients market is highly competitive, necessitating constant innovation and investment in manufacturing capabilities to maintain market share.
Start your research today
Unlock AI insights, financials, peers and live data on Sudeep Pharma and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Q1 FY27